Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03477006 · ClinicalTrials.gov registry record · Phase 3
Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial
A Phase 3 study, sponsored by Jason Sperry.
- Terminated
- Registry status
- Phase 3
- Development phase
- 86
- Enrollment target
NCT03477006 is a Phase 3 study that was terminated before completion, run by Jason Sperry. The registered enrollment target is 86 participants.
The verdict
NCT03477006, a Phase 3 study, was terminated before completion, sponsored by Jason Sperry.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 86 participants
- Enrollment target
Study Summary
Despite advances in trauma resuscitation, a paucity of therapeutic interventions are available early enough to reduce the downstream morbidity and mortality attributable to hemorrhage, shock and coagulopathy. Due to the time sensitive nature of the treatment of hemorrhage, the ideal resuscitation intervention would entail use of a blood product containing all essential hemostatic components, closest to time of injury, where prevention or reversal of the devastating downstream consequences of shock and coagulopathy can occur. This proposal will characterized the efficacy of whole blood resuscitation initiated in the prehospital setting to patients in hemorrhagic shock which represents this ideal intervention post-injury. These results will have great potential to dramatically change the way trauma resuscitation occurs today.
Interventions
- BIOLOGICAL Whole blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2018-11-20 |
| Est. Completion | 2020-10-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03477006
The ClinicalTrials.gov registry entry for NCT03477006 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jason Sperry, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole blood is the first listed.
NCT03477006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03477006 about?
NCT03477006 is a clinical study titled "Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial". Despite advances in trauma resuscitation, a paucity of therapeutic interventions are available early enough to reduce the downstream morbidity and mortality attributable to hemorrhage, shock and coagulopathy. Due to the time sensitive nature of the treatment of hemorrhage, the ideal resuscitation in...
What is the current status of trial NCT03477006?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 86 participants. The study started on 2018-11-20. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT03477006?
The interventions under investigation include: Whole blood (BIOLOGICAL).
Who is sponsoring clinical trial NCT03477006?
This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.